Amarin Corp - ADR

-0.10 (-1.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.97B
Current PEN/A
Forward PE N/A
2yr Forward PE 250.5
See more stats
Estimates Current Quarter
Revenue$147.98 Million
Adjusted EPS-$0.05
See more estimates
10-Day MA$5.52
50-Day MA$6.58
200-Day MA$5.83
See more pivots

Amarin Corp. Plc Stock, NASDAQ:AMRN

77 Sir John Rogerson's Quay, Grand Canal Docklands, Dublin, Dublin 2
United Kingdom
Phone: +353.1.6699020
Number of Employees: 965


Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.